FRACCHIOLLA, NICOLA STEFANO
FRACCHIOLLA, NICOLA STEFANO
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
2023 J. Salmanton-García, F. Marchesi, M. Gomes da Silva, F. Farina, J. Dávila-Valls, Y.M. Bilgin, A. Glenthøj, I. Falces-Romero, J. Van Doesum, J. Labrador, C. Buquicchio, S. El-Ashwah, V. Petzer, J. Van Praet, M. Schönlein, M. Dargenio, G. Méndez, S. Meers, F. Itri, A. Giordano, L.I. Pinczés, I. Espigado, Z. Stojanoski, A. López-García, L. Prezioso, O. Jaksic, A. Vena, N.S. Fracchiolla, T.J. González-López, N. Colović, M. Delia, B. Weinbergerová, M. Marchetti, J. Marques de Almeida, O. Finizio, C. Besson, M.M. Biernat, T. Valković, T. Lahmer, A. Cuccaro, I. Ormazabal-Vélez, J. Batinić, N. Fernández, N. De Jonge, C. Tascini, A.N. Anastasopoulou, R. Duléry, M.I. Del Principe, G. Plantefeve, M.V. Papa, M. Nucci, M. Jiménez, A. Aujayeb, J. Hernández-Rivas, M. Merelli, C. Cattaneo, O. Blennow, A. Nordlander, A. Cabirta, G. Varricchio, M.V. Sacchi, R. Cordoba, E. Arellano, S.K. Gräfe, D. Wolf, Z. Emarah, E. Ammatuna, D.S. Hersby, S. Martín-Pérez, R. Nunes Rodrigues, L. Rahimli, L. Pagano, O.A. Cornely
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV
2022 P. Zappasodi, C. Cattaneo, V. Valeria Ferretti, R. Mina, A. José María Ferreri, F. Merli, M. Oberti, M. Krampera, A. Romano, C. Zerbi, J. Ferrari, M. Cavo, M. Salvini, L. Bertù, N. Stefano Fracchiolla, F. Marchesi, M. Massaia, V. Marasco, R. Cairoli, A. Maria Scattolin, A. Maria Vannucchi, C. Gambacorti-Passerini, P. Musto, F. Gherlinzoni, A. Cuneo, A. Pinto, L. Trentin, M. Bocchia, S. Galimberti, E. Coviello, M. Chiara Tisi, A. Morotti, B. Falini, M. Turrini, A. Tafuri, A. Billio, M. Gentile, R. Massimo Lemoli, A. Venditti, M. Giovanni Della Porta, F. Lanza, L. Rigacci, P. Tosi, S. Mohamed, A. Corso, M. Luppi, N. Giuliani, A. Busca, L. Pagano, R. Bruno, P. Antonio Grossi, P. Corradini, F. Passamonti, L. Arcaini
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy
2021 E. Saccon, A. Bandera, M. Sciumè, F. Mikaeloff, A.A. Lashari, S. Aliberti, M.C. Sachs, F. Billi, F. Blasi, E.E. Gabriel, G. Costantino, P. De Roberto, S. Krishnan, A. Gori, F. Peyvandi, L. Scudeller, C. Canetta, C.L. Lorson, L. Valenti, K. Singh, L. Baldini, N.S. Fracchiolla, U. Neogi
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913
2021 S. Chiaretti, M. Messina, I.D. Starza, A. Piciocchi, L. Cafforio, M. Cavalli, A. Taherinasab, M. Ansuinelli, L. Elia, G.A. Petroni, R. la Starza, M. Canichella, A. Lauretti, M.C. Puzzolo, V. Pierini, A. Santoro, O. Spinelli, V. Apicella, S. Capria, F. Di Raimondo, P. de Fabritiis, C. Papayannidis, A. Candoni, R. Cairoli, M. Cerrano, N. Fracchiolla, D. Mattei, C. Cattaneo, A. Vitale, E. Crea, P. Fazi, C. Mecucci, A. Rambaldi, A. Guarini, R. Bassan, R. Foa
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy)
2020 B. Fattizzo, J.A. Giannotta, W. Barcellini, M.C. Barbanti, C. Bucelli, R. Cassin, D. Cattaneo, F. Cavallaro, V. Ferla, N.S. Fracchiolla, A. Freyrie, G. Galassi, M.C. Goldaniga, F.I. Grifoni, A. Iurlo, G. Mangiameli, V. Mattiello, M. Meli, A. Neri, A. Noto, F. Onida, L. Ottani, R. Pasquale, L. Pettine, A. Pompa, G. Reda, F.G. Rossi, G.N. Saporiti, M. Sciumè, E. Tagliaferri, L. Baldini
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects
2020 B. Fattizzo, J. Rosa, J.A. Giannotta, L. Baldini, N.S. Fracchiolla
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality
2020 B. Fattizzo, J.A. Giannotta, M. Sciume, D. Cattaneo, C. Bucelli, N.S. Fracchiolla, F. Onida, L. Baldini, W. Barcellini, A. Iurlo
Secondary acute myeloid leukaemia in elderly patients : Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions : an analysis of 280 patients by the network rete ematologica lombarda (REL)
2018 E. Borlenghi, C. Pagani, P. Zappasodi, M. Bernardi, C. Basilico, E. Todisco, N. Fracchiolla, V. Mancini, M. Turrini, M. Da Vià, E. Sala, C. Cattaneo, M. Petullà, F. Serana, A. Ferrario, R. Cairoli, A. Cortelezzi, A. Santoro, C. Castagnola, G. Rossi
Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network
2018 P. Zappasodi, L. Marbello, E. Borlenghi, M. Fumagalli, M. Bernardi, N. Fracchiolla, V. Mancini, M. Da Via, E. Ravano, E. Cerqui, V.V. Ferretti, B. Rocca, C. Calvello, M. Cazzola, C. Castagnola, G. Rossi
Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome–positive acute lymphoblastic leukemia
2018 M. Sciumè, N.S. Fracchiolla, A. Cortelezzi
Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications
2017 N.S. Fracchiolla, B. Fattizzo, A. Cortelezzi
FarmaREL : an Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients
2017 N.S. Fracchiolla, S. Artuso, A. Cortelezzi, A.M. Pelizzari, P. Tozzi, M. Bonfichi, F. Bocchio, L. Gargantini, E. De Rosa, G.D. Vighi, L. Prestini, S. Sammassimo, N. Frungillo, M.C. Pasquini, A. Ragazzi, D. Boghi, A. Pastore, E. Lanzi, G. Gritti, G. Quaresmini, S. Voltolini, R. Gaiardoni, C. Corti, M.C. Vilardo, M.L. La Targia, G. Berini, M. Magagnoli, C. Bacci, D. Consonni, A.L. Rivolta, G. Muti
Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies : a large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)
2017 N.S. Fracchiolla, E. Todisco, A. Bilancia, S. Gandolfi, N. Orofino, F. Guidotti, V. Mancini, L. Marbello, A. Assanelli, M. Bernardi, A. Santoro, R. Cairoli, D. Consonni, A. Cortelezzi
Concomitant Occurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukaemia after Lenalidomide Treatment for del(5q) Myelodysplastic Syndrome
2017 N.S. Fracchiolla, A. Iurlo, V. Ferla, B. Fattizzo, A. Freyrie, G. Reda, A. Cortelezzi
An unusual type of myeloid sarcoma localization following myelofibrosis : a case report and literature review
2017 N. Orofino, D. Cattaneo, C. Bucelli, L. Pettine, S. Fabris, U. Gianelli, N.S. Fracchiolla, A. Cortelezzi, A. Iurlo
PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis
2015 C. Augello, U. Gianelli, R. Falcone, S. Tabano, F. Savi, E. Bonaparte, M. Ciboddo, L. Paganini, A. Parafioriti, D. Ricca, S. Lonati, D. Cattaneo, N. Fracchiolla, A. Iurlo, A. Cortelezzi, S. Bosari, M. Miozzo, S. Sirchia
High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes
2013 U. Gianelli, N.S. Fracchiolla, P. Bucciarelli, V. Ferla, L. Boiocchi, F. Savi, A. Moro, G. Reda, S. Bosari, A. Cortelezzi
Dioxin exposure of human CD34(+) hemopoietic cells induces gene expression modulation that recapitulates its in vivo clinical and biological effects
2011 N.S. Fracchiolla, K. Todoerti, P.A. Bertazzi, F. Servida, P. Corradini, C. Carniti, A. Colombi, A. Pesatori, A. Neri, G. Lambertenghi-Deliliers
Prognostic implications of the European consensus for grading of bone marrow fibrosis in primary myelofibrosis: comparison with the prognostic scoring system of the IWGMRT
2010 C. Vener, U. Gianelli, A. Iurlo, N.S. Fracchiolla, A. Bossi, I. Cortinovis, G. Lambertenghi Deliliers
Prothrombotic gene mutations in patients with sudden sensorineural hearing loss and cardiovascular thrombotic
2009 P. Capaccio, V. Cuccarini, F. Ottaviani, N. Fracchiolla, A. Bossi, L. Pignataro